Zhejiang Huakang Pharmaceutical Co., Ltd.
SHH: 605077.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Basic Materials
- Industry
- Chemicals
- CEO
- Deshui Chen
- Employees
- 1,350
- Headquarters
- Quzhou, China
- IPO year
- 2021
- Market cap
- CN¥5.6B
- Website
- https://www.huakangpharma.com
Loading 605077…
Loading profile data…Frequently asked questions about 605077
What does Zhejiang Huakang Pharmaceutical Co., Ltd. (605077.SS) do?
Zhejiang Huakang Pharmaceutical Co., Ltd. engages in the research, production, and sale of polyols worldwide. Its products include xylitol, a polyol with close to sugar sweetness; sorbitol, a sugar alcohol being white crystal powder; maltitol, a sugar alcohol; xylose that is used in xylitol production; and L-arabinos, which can be used as sucros...
Where does 605077.SS trade?
Zhejiang Huakang Pharmaceutical Co., Ltd. (605077.SS) trades on the Shanghai Stock Exchange.
What sector is 605077.SS in?
Zhejiang Huakang Pharmaceutical Co., Ltd. (605077.SS) operates in the Basic Materials sector, specifically in the Chemicals industry.
Who is the CEO of Zhejiang Huakang Pharmaceutical Co., Ltd.?
Deshui Chen is the chief executive officer of Zhejiang Huakang Pharmaceutical Co., Ltd. (605077.SS).
Where is Zhejiang Huakang Pharmaceutical Co., Ltd. headquartered?
Zhejiang Huakang Pharmaceutical Co., Ltd. is headquartered in China.
Does 605077.SS pay a dividend?
Yes — Zhejiang Huakang Pharmaceutical Co., Ltd. (605077.SS) paid a trailing twelve-month dividend of CNY 0.20 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 605077.SS go public?
Zhejiang Huakang Pharmaceutical Co., Ltd. (605077.SS) completed its initial public offering in 2021.